Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Dec;35(12):1728–1733. doi: 10.1136/gut.35.12.1728

Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection.

G D'Haens 1, M Hiele 1, P Rutgeerts 1, K Geboes 1, J L Ceuppens 1
PMCID: PMC1375261  PMID: 7829010

Abstract

Earlier studies regarding possible primary immune disturbances participating in the pathogenesis of Crohn's disease yielded conflicting results. Peripheral blood lymphocyte subsets and lymphocyte proliferative responses to five soluble recall antigens and to the polyclonal stimulator phythaemagglutinin were therefore measured in 17 patients with active Crohn's disease, before and six months after surgical resection of the inflamed intestine and in 16 healthy controls. Lymphocyte proliferation in response to all five recall antigens was significantly lower in patients than in controls. No significant differences with controls were detected after surgery. Addition of indomethacin to phythaemagglutinin stimulated lymphocyte cultures had a stronger proliferation enhancing effect in patients than in controls, resulting in comparable proliferative responses in both groups. When both indomethacin and prostaglandin E2 were added, inhibition of reactivity by prostaglandin E2 was stronger in patients' cultures. This suggests a higher sensitivity to inflammatory prostaglandins in Crohn's disease. The degree of lymphocyte stimulation by antigens correlated positively with the percentage of circulating memory T cells (CD 45 RA-). The percentage of activated (HLA-DR+) CD8 cells was higher in patients than in controls. The CD4/CD8 ratio, which was not significantly different between patients and controls, correlated significantly with disease activity and characteristics, even in the postoperative phase. These findings suggest that immune abnormalities in Crohn's disease fluctuate with and are probably secondary to inflammatory activity.

Full text

PDF
1728

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auer I. O., Ziemer E. Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood. Klin Wochenschr. 1980 Aug 1;58(15):779–787. doi: 10.1007/BF01478286. [DOI] [PubMed] [Google Scholar]
  2. Auer I. O., Ziemer E., Sommer H. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood. Clin Exp Immunol. 1980 Oct;42(1):41–49. [PMC free article] [PubMed] [Google Scholar]
  3. Bird A. G., Britton S. No evidence for decreased lymphocyte reactivity in Crohn's disease. Gastroenterology. 1974 Nov;67(5):926–932. [PubMed] [Google Scholar]
  4. Bolton P. M., James S. L., Newcombe R. G., Whitehead R. H., Hughes L. E. The immune competence of patients with inflammatory bowel disease. Gut. 1974 Mar;15(3):213–219. doi: 10.1136/gut.15.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown S. M., Taub R. N., Present D. H., Janowitz H. D. Short-term lymphocyte cultures in regional enteritis. Lancet. 1970 May 23;1(7656):1112–1112. doi: 10.1016/s0140-6736(70)92776-5. [DOI] [PubMed] [Google Scholar]
  6. Chiodini R. J. Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbiol Rev. 1989 Jan;2(1):90–117. doi: 10.1128/cmr.2.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deusch K., Reich K. Immunological aspects of inflammatory bowel disease. Endoscopy. 1992 Aug;24(6):568–577. doi: 10.1055/s-2007-1010547. [DOI] [PubMed] [Google Scholar]
  8. Fais S., Pallone F., Squarcia O., Biancone L., Ricci F., Paoluzi P., Boirivant M. HLA-DR antigens on colonic epithelial cells in inflammatory bowel disease: I. Relation to the state of activation of lamina propria lymphocytes and to the epithelial expression of other surface markers. Clin Exp Immunol. 1987 Jun;68(3):605–612. [PMC free article] [PubMed] [Google Scholar]
  9. Goodwin J. S., Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol. 1983 Oct;3(4):295–315. doi: 10.1007/BF00915791. [DOI] [PubMed] [Google Scholar]
  10. Gould S. R. Assay of prostaglandin-like substances in faeces and their measurement in ulcerative colitis. Prostaglandins. 1976 Mar;11(3):489–497. doi: 10.1016/0090-6980(76)90095-2. [DOI] [PubMed] [Google Scholar]
  11. Gould S. R., Brash A. R., Conolly M. E. Increased prostaglandin production in ulcerative colitis. Lancet. 1977 Jul 9;2(8028):98–98. doi: 10.1016/s0140-6736(77)90111-8. [DOI] [PubMed] [Google Scholar]
  12. Haraoui B., Wilder R. L., Malone D. G., Allen J. B., Katona I. M., Wahl S. M. Immune function in severe, active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and mononuclear cell subset profiles. J Immunol. 1984 Aug;133(2):697–701. [PubMed] [Google Scholar]
  13. Hollander D. Crohn's disease--a permeability disorder of the tight junction? Gut. 1988 Dec;29(12):1621–1624. doi: 10.1136/gut.29.12.1621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kanof M. E., Strober W., Fiocchi C., Zeitz M., James S. P. CD4 positive Leu-8 negative helper-inducer T cells predominate in the human intestinal lamina propria. J Immunol. 1988 Nov 1;141(9):3029–3036. [PubMed] [Google Scholar]
  15. Kansas G. S., Wood G. S., Fishwild D. M., Engleman E. G. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8. J Immunol. 1985 May;134(5):2995–3002. [PubMed] [Google Scholar]
  16. MacDermott R. P., Stenson W. F. Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv Immunol. 1988;42:285–328. doi: 10.1016/s0065-2776(08)60848-2. [DOI] [PubMed] [Google Scholar]
  17. Morimoto C., Romain P. L., Fox D. A., Anderson P., DiMaggio M., Levine H., Schlossman S. F. Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases. Am J Med. 1988 May;84(5):817–825. doi: 10.1016/0002-9343(88)90058-7. [DOI] [PubMed] [Google Scholar]
  18. Mueller C., Knoflach P., Zielinski C. C. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology. 1990 Mar;98(3):639–646. [PubMed] [Google Scholar]
  19. Pallone F., Fais S., Squarcia O., Biancone L., Pozzilli P., Boirivant M. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut. 1987 Jun;28(6):745–753. doi: 10.1136/gut.28.6.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pitzalis C., Kingsley G., Murphy J., Panayi G. Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol. 1987 Nov;45(2):252–258. doi: 10.1016/0090-1229(87)90040-7. [DOI] [PubMed] [Google Scholar]
  21. Raedler A., Fraenkel S., Klose G., Seyfarth K., Thiele H. G. Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease. Gastroenterology. 1985 Apr;88(4):978–983. doi: 10.1016/s0016-5085(85)80017-2. [DOI] [PubMed] [Google Scholar]
  22. Sanders M. E., Makgoba M. W., Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today. 1988 Jul-Aug;9(7-8):195–199. doi: 10.1016/0167-5699(88)91212-1. [DOI] [PubMed] [Google Scholar]
  23. Schreiber S., Raedler A., Stenson W. F., MacDermott R. P. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clin North Am. 1992 Jun;21(2):451–502. [PubMed] [Google Scholar]
  24. Selby W. S., Jewell D. P. T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut. 1983 Feb;24(2):99–105. doi: 10.1136/gut.24.2.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shanahan F., Leman B., Deem R., Niederlehner A., Brogan M., Targan S. Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease. J Clin Immunol. 1989 Jan;9(1):55–64. doi: 10.1007/BF00917128. [DOI] [PubMed] [Google Scholar]
  26. Vane J. R. Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res. 1976;2:791–801. [PubMed] [Google Scholar]
  27. Verwilghen J., Vertessen S., Stevens E. A., Dequeker J., Ceuppens J. L. Depressed T-cell reactivity to recall antigens in rheumatoid arthritis. J Clin Immunol. 1990 Mar;10(2):90–98. doi: 10.1007/BF00918190. [DOI] [PubMed] [Google Scholar]
  28. Victorino R. M. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness. J Clin Lab Immunol. 1983 Aug;11(4):197–201. [PubMed] [Google Scholar]
  29. Wakefield A. J., Sankey E. A., Dhillon A. P., Sawyerr A. M., More L., Sim R., Pittilo R. M., Rowles P. M., Hudson M., Lewis A. A. Granulomatous vasculitis in Crohn's disease. Gastroenterology. 1991 May;100(5 Pt 1):1279–1287. [PubMed] [Google Scholar]
  30. Williams W. J. A study of Crohn's syndrome using tissue extracts and the Kveim and Mantoux tests. Gut. 1965 Oct;6(5):503–505. doi: 10.1136/gut.6.5.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yu D. T., Winchester R. J., Fu S. M., Gibofsky A., Ko H. S., Kunkel H. G. Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med. 1980 Jan 1;151(1):91–100. doi: 10.1084/jem.151.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yuan S. Z., Hanauer S. B., Kluskens L. F., Kraft S. C. Circulating lymphocyte subpopulations in Crohn's disease. Gastroenterology. 1983 Dec;85(6):1313–1318. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES